Themis Medicare Recommends Bhaskar Vemban Iyer's Re-appointment as Independent Director
Themis Medicare Ltd 路 Others (Uncategorized) 路 24 Oct 2026, 2:31 am
Themis Medicare Recommends Bhaskar Vemban Iyer's Re-appointment as Independent Director Themis Medicare's Board of Directors has recommended the re-appointment of Mr. Bhaskar Vemban Iyer as an Independent Director for a second consecutive term of five years, effective from 12th Nov'26, subject to shareholder approval. His first term concludes on 11th Nov'26. The company completed dispatching the Postal Ballot Notice to members on 23rd Oct'26 to seek requisite approval for the proposed tenure extension.
Original exchange filing (PDF)
More announcements from Themis Medicare Ltd
- Please refer to the attachment 路 16 Nov 2026
- Themis Medicare Limited has submitted to the Exchange, the un-audited standalone & consolidated financial results for the quarter and half year ended September 30, 2026. 路 14 Nov 2026
- Kindly refer to the Un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026 路 14 Nov 2026
- Kindly refer to the Outcome of the Board Meeting held on 14.11.2026 路 14 Nov 2026
- Themis Medicare Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- THEMISMED : 14-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 05, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2026, To consider and approve the un-audited standalone & consolidated financial results for the period ended September 30, 2026 路 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd 路 30 Oct 2026
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October .... 路 29 Oct 2026
